BIOMAT Database Logo BIOMAT Database Logo

[Living attenuated measles-virus vaccine. V. Protective affects and persistent immunity after inoculation with a living measles vaccine]. 1965

H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko

UI MeSH Term Description Entries
D007110 Immunity, Active Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. Active Immune Response,Active Immune Responses,Active Immunities,Active Immunity,Immune Response, Active,Immune Responses, Active,Immunities, Active,Response, Active Immune,Responses, Active Immune
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
[Living attenuated measles-virus vaccine. IV. Serological response of children before and after immunization with a living measles-virus vaccine].
January 1965, Nihon Ika Daigaku zasshi,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.
August 1962, The New England journal of medicine,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
[Persistence of immunity to attenuated measles live vaccine. V. Persistence of immunity after primary immunization with 4 strains of live measles vaccine].
August 1983, Zhonghua yi xue za zhi,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
[Inoculation of highly attenuated measles vaccine].
October 1969, Nihon Shonika Gakkai zasshi. Acta paediatrica Japonica,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
Attenuated measles-virus vaccine studies in Israel. I. Comparison of reactions after inoculation of vaccine with gamma-globulin.
March 1962, American journal of diseases of children (1960),
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
[Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
March 1967, Nihon Shonika Gakkai zasshi. Acta paediatrica Japonica,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
February 1965, Japanese journal of medical science & biology,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
Use of living attenuated measles-virus vaccine in early infancy.
August 1960, The New England journal of medicine,
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin.
March 1962, American journal of diseases of children (1960),
H Akamatsu, and M Yamamoto, and S Sekiya, and H Yamamoto, and I Kaneko
Attenuated measles virus as a vaccine vector.
April 2007, Vaccine,
Copied contents to your clipboard!